Global Paper Diagnostics Market By Product Type (Dipsticks, Paper-Based Microfluidics, and Lateral Flow Assays), By Device Type (Diagnostic Devices, and Monitoring Devices), By End-Use (Hospital and Clinics, Home Healthcare, and Assisted Living Healthcare Facilities), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Paper Diagnostics Market Overview:

The global paper diagnostics market was worth USD 7,798 million in 2021. Over the forecast period, the market is expected to grow at an annual rate (CAGR) of 8.2%.

Because of the growing demand for affordable healthcare in developing countries, point-of-care diagnostic methods are becoming more popular. Increased adoption of point-of-care pregnancy and diabetes test kits is expected to benefit the market in developed countries. Changing lifestyle habits like smoking and eating unhealthy foods can increase lifestyle-related diseases like diabetes and heart disease.

Global Paper Diagnostics Market Scope:

Product Type Analysis

In 2021, the lateral flow segment was responsible for more than 54.2% of the revenue share. This segment’s growth can be attributed to its high usage of pregnancy tests and various product types. The forecast period will also increase the incidence of infectious diseases like HIV, TB, or pneumonia.

Due to the increasing demand for point-of-care testing and R&D investments made by pharmaceutical and life sciences companies, the paper-based microfluidics market is expected to experience significant growth. This medical diagnostic device is made from paper and helps to detect biomarkers as well as identify diseases by performing an electrochemical analysis.

Device Type Analysis

In 2021, diagnostic devices accounted for the largest revenue share in the market. In blood separation and glucose detection, paper diagnostic devices are used. The segment is expected to grow as more people become aware of its benefits, including improved intensity, quality, and frequency of diagnosis, new product launches, approvals, and increased market share.

The potential for diagnostics devices to grow is enhanced by novel wax patterning technology. This allows for greater flexibility and adaptability. The segment’s growth is expected to be boosted by the rising popularity of microfluidics devices for urinalysis.

The forecast period also shows healthy growth for monitoring devices. This is due to increased devices used in applications that include food testing and nutrient monitoring within aquatic systems. The overall market for paper diagnostics will grow due to the increasing incorporation of government agencies.

End-Use Analysis

Home Healthcare will likely register a CAGR greater than 7.8% over the forecast period. The key factor driving the segment’s growth is the high adoption of in-home pregnancy and diabetes testing kits. The segment is also experiencing a growing interest in affordable healthcare and government initiatives.
Biotech pharma research institutes use paper-based molecular assays such as ELISA, and cell and nucleic acids assays. These diagnostics can be used to aid in drug discovery and clinical development. The segment is poised for growth due to the growing R&D and fundraising activity in emerging countries.

Кеу Маrkеt Ѕеgmеntѕ:

By Product Type

• Dipsticks
• Paper-Based Microfluidics
• Lateral Flow Assays

By Device Type

• Diagnostic Devices
• Monitoring Devices

By End-Use

• Hospital and Clinics
• Home Healthcare
• Assisted Living Healthcare Facilities

Market Dynamics:

In-vitro diagnostics devices and tests have seen a rise in investment by governments. The European Diagnostic Manufacturers Association, which focuses on developing and growing in vitro Diagnostic Industry in Europe each year, invests around EUR 1,000 million in R&D in vitro diagnostics.

APAC is poised for significant growth due to the increasing focus of Japanese players on paper diagnostics. Increasing healthcare initiatives and clinical development frameworks in emerging economies will also help. Hospitals and doctors in India are focusing on providing quality care and using diagnostic techniques due to the rising incidence of hospital-acquired infections of the urinary tract.

The market is expected to be influenced by the urgent need for new systems, replacement, and up-gradation in medical infrastructure. The market is expected to grow due to the untapped opportunities in emerging countries such as India, China, and Brazil in point-of-care diagnostics using paper.

Regional Analysis:

The Asia Pacific was the dominant market for paper diagnostics in 2021, accounting for 39.9% of the total revenue. In 2021, it was the most populated market. Due to the growing popularity of paper diagnostics, this region will also see the greatest growth over the forecast period. China, India, and Singapore have been at the forefront of this industry, with the largest consumer base for paper-based diagnosing tools. The Asia Pacific has been able to dominate the world due to its greater power in product pricing, thanks to the presence of large healthcare and pharmaceutical manufacturing companies in India and China.

North America’s projected growth rate is 6.3% between 2023 and 2032. This is due to the country’s increasing investment in alternative healthcare facilities and new product solutions for diagnosing. The United States holds many of the leading players in the market. They also have some of the most advanced R&D facilities around the globe to offer their customers some of the most innovative products.
Europe is a notable consumer market player in this market. It is expected to maintain a 28.2% market share by 2032. Due to their large investment in healthcare facilities, the UK and Germany are the two largest countries in this region.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

ARKRAY Inc., Acon Laboratories, Inc., Abbott, Bio-Rad Laboratories, and Siemens Healthcare GmbH are key players. These players have adopted high R&D investments in order to create new product portfolios. This is one of their key strategies to gain shares. In FY 2017, Abbott spent USD 2,240 million on research and development activities. The company also has HIV Combo Fingersticks, SD BIOLINE HAT 2.0, and Malaria Ag The company offers a range of test products to the market.

In 2018, ARKRAY, Inc. also completed the expansion of and transfer to its Pinghu plant in China. This was done in order to increase its manufacturing capabilities for diabetes testing instruments as well as in vitro diagnostic reagents. The company plans to expand its China presence through R&D unit expansion.
Other emerging players, including Abcam Plc, Chembio Diagnostic Systems, Inc., and Creative Diagnostics, continue to focus on product development and expand their presence in developing countries to seize untapped opportunities.

Маrkеt Кеу Рlауеrѕ:

• ARKRAY Inc.
• Acon Laboratories Inc.
• Abbott
• Bio-Rad Laboratories
• Siemens healthcare Gmbh
• Abcam Plc
• Chembio Diagnostic Systems Inc.
• Creative Diagnostics
• Other Key Players

For the Paper Diagnostics Market research study, the following years have been considered to estimate the market size: